M Tramontana Selected Research

M Tramontana Research Topics

Disease

5	Inflammation (Inflammations) 12/2010 - 05/2000
3	Hyperalgesia 04/2016 - 05/2000
3	Colitis 04/2016 - 10/2001
2	Hypersensitivity (Allergy) 11/2021 - 04/2016
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2016 - 10/2000
2	Hypotension (Low Blood Pressure) 04/2002 - 03/2001
1	COVID-19 08/2022
1	Eczema 08/2022
1	Atopic Dermatitis (Atopic Eczema) 08/2022
1	Granuloma Annulare 12/2021
1	Allergic Contact Dermatitis 05/2020
1	Bullous Pemphigoid (Pemphigoid) 03/2015
1	Arthralgia (Joint Pain) 12/2010
1	Arthritis (Polyarthritis) 12/2010
1	Joint Diseases (Joint Disease) 12/2010
1	Tachycardia (Tachyarrhythmias) 04/2002
1	Proctocolitis (Hemorrhagic Proctocolitis) 10/2001
1	Enteritis 10/2001
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2001
1	Diarrhea 10/2001
1	Asthma (Bronchial Asthma) 10/2000
1	Abnormal Reflex (Hyperreflexia) 10/2000
1	Cystitis 05/2000

Drug/Important Bio-Agent (IBA)

4	TachykininsIBA 04/2016 - 10/2000
3	BradykininIBA 12/2010 - 03/2001
2	AcidsIBA 04/2016 - 10/2008
2	AntigensIBA 03/2015 - 01/2007
2	KininsIBA 12/2010 - 04/2002
2	2,5-dichloro-4-bromophenol (B 2)IBA 12/2010 - 03/2001
2	icatibantIBA 04/2002 - 03/2001
2	MEN 11270IBA 04/2002 - 03/2001
2	Peptides (Polypeptides)IBA 10/2001 - 03/2001
1	dupilumabIBA 08/2022
1	apremilastIBA 12/2021
1	AcrylatesIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 05/2020
1	Ethanol (Ethyl Alcohol)IBA 04/2016
1	ibodutantIBA 04/2016
1	AutoantibodiesIBA 03/2015
1	(4- amino- 5- (4- (4- (2,4- dichloro- 3- (2,4- dimethyl- 8- quinolyloxymethyl)phenylsulfonamido)tetrahydro- 2H- 4- pyranoylcarbonyl)piperazino)- 5- oxopentyl)(trimethyl)ammoniumIBA 12/2010
1	SteroidsIBA 12/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2010
1	Analgesics (Analgesic Drugs)IBA 12/2010
1	LipopolysaccharidesIBA 12/2010
1	CarrageenanIBA 12/2010
1	NK 2 (NK-2)IBA 10/2008
1	Peroxidase (Myeloperoxidase)IBA 10/2008
1	NeuropeptidesIBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008
1	SolutionsIBA 10/2008
1	Substance PIBA 10/2008
1	Neurokinin AIBA 10/2008
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 10/2008
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2007
1	montelukast (Singulair)FDA Link 01/2007
1	MEN91507IBA 01/2007
1	Cyclic PeptidesIBA 04/2002
1	AminopeptidasesIBA 04/2002
1	Castor Oil (Oil, Castor)IBA 10/2001
1	Bacterial ToxinsIBA 10/2001
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2001
1	MEN 11420 (Nepadutant)IBA 10/2001
1	Peptide Receptors (Peptide Receptor)IBA 03/2001
1	FR 173657IBA 03/2001
1	Tachykinin Receptors (Tachykinin Receptor)IBA 10/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2000
1	ProstaglandinsIBA 05/2000
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2000
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2000
1	dexketoprofen trometamol (Keral)IBA 05/2000
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 05/2000
1	IsoenzymesIBA 05/2000
1	EndotoxinsIBA 05/2000

Therapy/Procedure

1	Rectal Administration 04/2016
1	Therapeutics 12/2010
1	Topical Administration 04/2002
1	Oral Administration 10/2001